Von Willebrand Disease: From In Vivo to In Vitro Disease Models

Area of Science:

• Hematology
• Cell Biology
• Genetics

Background:

• Von Willebrand factor (VWF) is essential for primary hemostasis, mediating platelet adhesion after vascular injury.
• Defects in VWF cause von Willebrand disease (VWD), the most common inherited bleeding disorder, with varying clinical presentations.
• Understanding VWF synthesis, storage, and secretion in producing cells is key to investigating VWD pathophysiology.

Purpose of the Study:

• To review existing and novel cell models for studying von Willebrand disease (VWD) and von Willebrand factor (VWF).
• To discuss the limitations of current models and the potential of new approaches for VWD research.
• To enhance the understanding of the structural and functional mechanisms underlying VWD.

Main Methods:

• Review of literature on cell models used in VWD and VWF research.
• Analysis of primary cell models (endothelial cells, megakaryocytes) and transfected cell lines.
• Evaluation of emerging models including endothelial colony-forming cells (ECFCs) and induced pluripotent stem cells (iPSCs).

Main Results:

• Transfected heterologous cells have aided VWF synthesis research but lack primary cell characteristics.
• Primary cell isolation is invasive; ECFCs offer a more accessible, nature-true model.
• iPSCs present a versatile potential source for endothelial cells and megakaryocytes for VWD studies.

Conclusions:

• Current models for studying VWD have limitations, necessitating the exploration of novel approaches.
• Endothelial colony-forming cells (ECFCs) and induced pluripotent stem cells (iPSCs) show promise for advancing VWD research.
• Improved cell models are crucial for a deeper understanding of the molecular mechanisms driving VWD.